QMS Medical Allied Services Limited — PPTs, 17-08-2026: Investor Presentation

QMS Medical Allied Services kicked off the latest quarter strong. Revenue surged 22% year-on-year to Rs 56.9 Cr, with EBITDA jumping 27% to Rs 8.3 Cr, achieving a 14.6% margin. Profit after tax (PAT) climbed 25% to Rs 4 Cr. Both Products (59% of revenue) and Services (41%) segments showed solid traction, driven by an expanding network and pharma partnerships respectively.

The company's strategy focuses on scaling Patient Support Programs (PSPs), bolstering partnerships, expanding its Q-Devices and Point-of-Care solutions, and leveraging its tech platform for integrated healthcare. Access through the eGrameen portal is also boosting rural reach.

Recent wins include acquiring a 76% stake in Saarathi Healthcare to enhance disease management, with full acquisition targeted by the next quarter. QMS also conducted 11,497 B2B health camps and recently moved to the NSE Main Board. Management is upbeat about continued sustainable growth.